UNCY

Unicycive Therapeutics, Inc.

$5.73 +0.45 (+8.52%) At close · Jul 2

Market Cap

$152.99M

26,700,027

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Date	Insider	Role	Type	Shares	Price	Value	After
2026-05-14	Gupta Pramod	EVP, Pharmaceuticals and BD	Award	169,500	—	—	169,500
2026-05-14	Kenkare-Mitra Sara	Director	Award	42,100	—	—	126,300
2026-05-14	Kenkare-Mitra Sara	Director	Award	84,200	—	—	84,200
2026-05-14	Laumas Sandeep	CFO and CBO	Award	84,200	—	—	84,200
2026-05-14	Laumas Sandeep	CFO and CBO	Award	42,100	—	—	126,300
2026-05-14	Townsend John	Chief Financial Officer	Award	169,500	—	—	169,500
2026-05-14	Jermasek Douglas	EVP of Corporate Strategy	Award	169,500	—	—	169,500
2026-05-14	Gupta Shalabh K.	Director, CEO	Award	762,200	—	—	762,200
2025-08-25	Aggarwal Gaurav	Director	Other	652,900	—	—	1,789,915
2025-08-25	Aggarwal Gaurav	Director	Other	3,199	$1,000.00	$3,199,000	0
2025-07-28	Aggarwal Gaurav	Director	Award	21,200	—	—	39,200
2025-07-28	Laumas Sandeep	CFO and CBO	Award	21,200	—	—	41,286
2025-07-28	Townsend John	Chief Financial Officer	Award	10,000	—	—	101,557
2025-07-28	Gupta Pramod	EVP, Pharmaceuticals and BD	Award	90,000	—	—	301,986
2025-07-28	Jermasek Douglas	EVP of Corporate Strategy	Award	10,000	—	—	215,500
2025-07-28	Gupta Shalabh K.	Director, CEO	Award	325,000	—	—	968,951
2025-07-28	Kenkare-Mitra Sara	Director	Award	21,200	—	—	39,200
2025-02-18	Aggarwal Gaurav	Director	Other	686	$1,000.00	$686,000	3,119
2025-02-18	Aggarwal Gaurav	Director	Other	1,400,000	—	—	11,370,152
2024-10-09	Aggarwal Gaurav	Director	Other	2,695	$1,000.00	$2,695,000	3,885
2024-10-09	Aggarwal Gaurav	Director	Other	5,500,000	—	—	9,970,152
2024-08-12	Gupta Pramod	EVP, Pharmaceuticals and BD	Award	81,750	—	—	2,119,862
2024-08-12	Townsend John	Chief Financial Officer	Award	40,256	—	—	915,565
2024-08-12	Jermasek Douglas	EVP of Corporate Strategy	Award	81,750	—	—	2,055,000
2024-08-12	Gupta Shalabh K.	Director, CEO	Award	232,868	—	—	6,439,505
2024-04-15	Jermasek Douglas	EVP of Corporate Strategy	Award	463,250	—	—	1,973,250
2024-04-15	Gupta Shalabh K.	Director, CEO	Award	1,319,583	—	—	6,206,637
2024-04-15	Townsend John	Chief Financial Officer	Award	228,119	—	—	875,309
2024-04-15	Gupta Pramod	EVP, Pharmaceuticals and BD	Award	463,250	—	—	2,038,112
2023-09-05	Laumas Sandeep	CFO and CBO	Award	189,236	—	—	200,864
2023-09-05	Kenkare-Mitra Sara	Director	Award	180,000	—	—	180,000
2023-09-05	Ryan John L	Director	Award	112,147	—	—	123,775
2023-09-05	Aggarwal Gaurav	Director	Award	180,000	—	—	180,000
2023-09-05	Kenkare-Mitra Sara	Director	Other	0	—	—	0
2023-08-28	Gupta Shalabh K.	Director, CEO	Award	4,684,775	—	—	4,988,798
2023-08-28	Jermasek Douglas	EVP of Corporate Strategy	Award	1,355,000	—	—	1,510,000
2023-08-28	Townsend John	Chief Financial Officer	Award	570,329	—	—	647,190
2023-08-28	Gupta Pramod	EVP, Pharmaceuticals and BD	Award	1,355,000	—	—	1,574,862
2023-07-11	Jermasek Douglas	EVP of Corporate Strategy	Convert	72,047	—	—	72,047
2023-07-11	Gupta Pramod	EVP, Pharmaceuticals and BD	Convert	46,110	—	—	46,110
2023-07-11	Gupta Shalabh K.	Director, CEO	Convert	104,612	—	—	2,527,449
2023-07-11	Jermasek Douglas	EVP of Corporate Strategy	Convert	104,612	—	—	175,012
2023-07-11	Gupta Pramod	EVP, Pharmaceuticals and BD	Convert	20	$1,000.00	$20,000	0
2023-07-11	Gupta Shalabh K.	Director, CEO	Convert	72,047	—	—	72,047
2023-07-11	Jermasek Douglas	EVP of Corporate Strategy	Convert	79,252	—	—	79,252
2023-07-11	Jermasek Douglas	EVP of Corporate Strategy	Convert	50	$1,000.00	$50,000	0
2023-07-11	Gupta Pramod	EVP, Pharmaceuticals and BD	Convert	41,845	—	—	41,845
2023-07-11	Gupta Shalabh K.	Director, CEO	Convert	79,252	—	—	79,252
2023-07-11	Gupta Shalabh K.	Director, CEO	Convert	115,275	—	—	115,275
2023-07-11	Aggarwal Gaurav	Director	Other	12,802,388	—	—	12,802,388

Showing 1–50 of 75 transactions

Key facts CIK 1766140 CUSIP 90466Y202 Visit website Investor relations